These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10972209)

  • 41. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
    Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection.
    Yannoutsos N; Ijzermans JN; Harkes C; Bonthuis F; Zhou CY; White D; Marquet RL; Grosveld F
    Genes Cells; 1996 Apr; 1(4):409-19. PubMed ID: 9135084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29.
    Bjørge L; Jensen TS; Ulvestad E; Vedeler CA; Matre R
    Scand J Immunol; 1995 Apr; 41(4):350-6. PubMed ID: 7534941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
    Gelderman KA; Kuppen PJ; Bruin W; Fleuren GJ; Gorter A
    Eur J Immunol; 2002 Jan; 32(1):128-35. PubMed ID: 11754353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination.
    Ménoret S; Plat M; Blancho G; Martinat-Botté F; Bernard P; Karam G; Tesson L; Renaudin K; Guillouet P; Weill B; Chéreau C; Houdebine LM; Soulillou JP; Terqui M; Anegon I
    Transplantation; 2004 May; 77(9):1468-71. PubMed ID: 15167611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of the complement regulatory function of CD59 by site-directed mutagenesis at the N-glycosylation site.
    Akami T; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Nakai I; Mitsuo M; Sawada R; Naruto M; Oka T
    Transplant Proc; 1994 Jun; 26(3):1256-8. PubMed ID: 7518124
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
    Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
    [No Abstract]   [Full Text] [Related]  

  • 50. The generation of transgenic pigs as potential organ donors for humans.
    Cozzi E; White DJ
    Nat Med; 1995 Sep; 1(9):964-6. PubMed ID: 7585226
    [No Abstract]   [Full Text] [Related]  

  • 51. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
    Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
    Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysis.
    Hayashi S; Isobe K; Emi N; Okada H; Yasutomi M; Negita M; Koike C; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1995 Feb; 27(1):330. PubMed ID: 7533402
    [No Abstract]   [Full Text] [Related]  

  • 53. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S; van den Berg CW
    Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
    Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
    Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of cell-surface glycoproteins in the activation of endothelial cells by antibody and complement.
    Lindman BJ; Noreen HJ; Geller RL; Dalmasso AP; Bach FH; Platt JL
    Transplant Proc; 1992 Apr; 24(2):586-7. PubMed ID: 1566439
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection.
    Niemann H; Verhoeyen E; Wonigeit K; Lorenz R; Hecker J; Schwinzer R; Hauser H; Kues WA; Halter R; Lemme E; Herrmann D; Winkler M; Wirth D; Paul D
    Transplantation; 2001 Dec; 72(12):1898-906. PubMed ID: 11773886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59.
    Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL
    Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120
    [No Abstract]   [Full Text] [Related]  

  • 59. K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement.
    Jurianz K; Ziegler S; Donin N; Reiter Y; Fishelson Z; Kirschfink M
    Int J Cancer; 2001 Sep; 93(6):848-54. PubMed ID: 11519047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.
    Shinkel TA; Cowan PJ; Barlow H; Aminian A; Romanella M; Lublin DM; Pearse MJ; d'Apice AJ
    Transplantation; 1998 Dec; 66(11):1401-6. PubMed ID: 9869079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.